Lisa L. Bollinger's most recent trade in Apogee Therapeutics Inc. was a trade of 14,461 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Apogee Therapeutics Inc. | Lisa L. Bollinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 14,461 | 14,461 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc. | Lisa L. Bollinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 8,112 | 8,112 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc. | Lisa L. Bollinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 18,550 | 18,550 | - | - | Stock Option (Right to Buy) |